Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has shared an announcement.
Fuso Pharmaceutical Industries, Ltd. announced personnel changes in its executive officer team following a Board of Directors meeting on June 25, 2025. The changes include the appointment of new executive officers and the reappointment of six current members, indicating a strategic move to strengthen its leadership structure.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the production and development of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market.
Average Trading Volume: 21,341
Technical Sentiment Signal: Sell
Current Market Cap: Yen18.3B
See more data about 4538 stock on TipRanks’ Stock Analysis page.